Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPH0655218B2 - Artificial basement membrane and method for producing the same - Google Patents
[go: Go Back, main page]

JPH0655218B2 - Artificial basement membrane and method for producing the same - Google Patents

Artificial basement membrane and method for producing the same

Info

Publication number
JPH0655218B2
JPH0655218B2 JP61004310A JP431086A JPH0655218B2 JP H0655218 B2 JPH0655218 B2 JP H0655218B2 JP 61004310 A JP61004310 A JP 61004310A JP 431086 A JP431086 A JP 431086A JP H0655218 B2 JPH0655218 B2 JP H0655218B2
Authority
JP
Japan
Prior art keywords
basement membrane
producing
same
artificial basement
artificial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP61004310A
Other languages
Japanese (ja)
Other versions
JPS62270162A (en
Inventor
慎一郎 楠
辰寿 瀬川
富美男 中村
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Advance KK
Original Assignee
Advance KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advance KK filed Critical Advance KK
Priority to JP61004310A priority Critical patent/JPH0655218B2/en
Publication of JPS62270162A publication Critical patent/JPS62270162A/en
Publication of JPH0655218B2 publication Critical patent/JPH0655218B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Materials For Medical Uses (AREA)

Description

【発明の詳細な説明】 本発明は、人工基底膜及びその製造方法に関する。基底
膜は、上皮細胞、内皮細胞及び中皮細胞の基底面に存在
するコラーゲンと糖蛋白質を主成分とする細胞間質であ
る。現在、基底膜は癌の転移や上皮一間充織糸における
上皮細胞の増殖制御の調節等、生物学的に重要な役割を
果していることが判明してきている。しかし、この基底
膜はin vitroで人工的に作成することは一般に極めて難
しく、又、ラミニンタイプIVコラーゲン、HSPGS
(ヘパラン硫酸、プロテオグリカン等)を主成分として再
構成させる方法では、生成された人工基底膜は生体組織
内のものとは著しくその構造が異なっていた。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to an artificial basement membrane and a method for producing the same. The basement membrane is a cell stroma mainly composed of collagen and glycoprotein existing on the basal surface of epithelial cells, endothelial cells and mesothelial cells. At present, it has been revealed that the basement membrane plays an important biological role such as metastasis of cancer and regulation of growth control of epithelial cells in epithelial-mesenchymal yarn. However, it is generally extremely difficult to artificially make this basement membrane in vitro, and laminin type IV collagen, HSPGS, etc.
In the method of reconstituting (heparan sulfate, proteoglycan, etc.) as the main component, the artificial basement membrane produced was remarkably different in structure from that in the living tissue.

上記に鑑み、本発明者らはコラーゲンゲル内に繊維芽細
胞をうめ込んだ凝結合織上に、基底膜要素を重層培養す
ることで天然の基底膜と構造的に極めて均等な人工基底
膜を製造することに成功した。また上記方法で作成した
再構成基底膜上で皮膚由来上皮細胞を培養したところ、
著しく優れた増殖能を示し、3週間経過時には、上皮細
胞の均一な多層構造の形成を光学及び電子顕微鏡で観察
することができた。さらに上述した培養皮膚をネズミに
移植したところ、創傷治癒も著しく昂進され、またケロ
イド状瘢痕も全く認められなかった。
In view of the above, the present inventors have established an artificial basement membrane structurally extremely equivalent to the natural basement membrane by layer-culturing the basement membrane elements on the cohesive weave in which fibroblasts are embedded in the collagen gel. Succeeded in manufacturing. When skin-derived epithelial cells were cultured on the reconstituted basement membrane prepared by the above method,
It showed remarkably excellent proliferative ability, and after 3 weeks, formation of a uniform multi-layer structure of epithelial cells could be observed by light and electron microscopy. Furthermore, when the above-mentioned cultured skin was transplanted into a rat, wound healing was markedly promoted and no keloid scar was observed at all.

以下、本発明の構成等につき詳細に分説する。The constitution of the present invention will be described in detail below.

基底膜構成成分 本発明において、基底膜構成成分は適量のtypeIVコラー
ゲン(BRL社製)、ラミニン(BRL社製)、及びファブ
ロネクチン(BRL社製)を含むMEM培地10%FCS
溶液とした。
Basement Membrane Constituent In the present invention, the basement membrane constituent is a MEM medium 10% FCS containing appropriate amounts of type IV collagen (manufactured by BRL), laminin (manufactured by BRL), and fabronectin (manufactured by BRL).
It was a solution.

又、基板となる繊維芽細胞含有ゲルとしては、適量のty
peIコラーゲン(またはアテロコラーゲン)を含むMEM
培地10%FCS溶液を使用した。尚、上記2溶液にヘ
パラン硫酸、コンドロイチン硫酸、ニドゲン及びエンタ
クチン等を微量に加えることにより、人工基底膜がより
良好に製造できることも確認された。
In addition, as a fibroblast-containing gel that serves as a substrate, an appropriate amount of ty
MEM containing peI collagen (or atelocollagen)
A medium 10% FCS solution was used. It was also confirmed that the artificial basement membrane can be produced better by adding a small amount of heparan sulfate, chondroitin sulfate, nidogen, entactin, etc. to the above two solutions.

再構成基底膜の製造 再構成基底膜は、使用対象に応じて構成因子の動物種を
選択することが必要であるが、細胞性免疫を考慮すると
基底膜内に極力細胞を含まないことが望ましい。
Manufacture of reconstituted basement membrane It is necessary to select the animal species of the reconstituted basement membrane according to the intended use, but considering cell-mediated immunity, it is desirable to contain as few cells as possible in the basement membrane. .

以上の見地から次のような方法で基底膜を製造した。From the above viewpoint, the basement membrane was produced by the following method.

第1図は本発明再構成基底膜の製造方法の1つを模式的
に示したものであり、繊維芽細胞を組み込んだtypeIコ
ラーゲンゲル1上に細胞を含まないtypeIコラーゲンゲ
ル2を重層、さらにその上に基底膜構成成分3を重層し
てある。このときの培養条件は5%CO2、95%大
気、37℃とする。
FIG. 1 schematically shows one of the methods for producing the reconstituted basement membrane of the present invention, in which type I collagen gel 2 containing no cells is layered on type I collagen gel 1 incorporating fibroblasts, and further, The basement membrane constituent 3 is layered thereon. The culture conditions at this time are 5% CO 2 , 95% air, and 37 ° C.

尚、このとき1層と2層の間にミリポアフィルター(ミ
リポア社製)等間隔を挟み込むと、基底膜中への細胞の
混入をさらに妨げることができる。
At this time, if a Millipore filter (manufactured by Millipore) is sandwiched between the first layer and the second layer at equal intervals, it is possible to further prevent the cells from being mixed into the basement membrane.

又、第2図に模式的に示した様に、繊維芽細胞を組み込
んだtyplIコラーゲンゲル1上に基底膜成分3を重層
し、5%CO2、95%大気で7日間培養後5%CO2
50%O2、45%N2に条件を変えて3日間培養する方
法も有効である。これは、繊維芽細胞が高酸素濃度下で
は増殖阻害される性質を利用したものである。この方法
に従うと前記方法に比べ、繊維芽細胞と再構成成分とが
直接接する機会が多いため、人工基底膜の構造を頑強に
することができ、さらに再構成基底膜中に繊維芽細胞が
混入することを防ぐことができる。
In addition, as schematically shown in FIG. 2, basement membrane component 3 was overlaid on typlI collagen gel 1 incorporating fibroblasts, and cultured for 5 days in 5% CO 2 and 95% atmosphere, and then 5% CO 2. 2 ,
A method of culturing for 3 days under different conditions of 50% O 2 and 45% N 2 is also effective. This utilizes the property that fibroblasts are growth-inhibited under high oxygen concentration. According to this method, compared to the above method, there are many opportunities for the fibroblasts and the reconstituted components to come into direct contact with each other, so that the structure of the artificial basement membrane can be made robust, and further, the fibroblasts are mixed in the reconstituted basement membrane. Can be prevented.

以下本発明を実験例により詳細に説明する。Hereinafter, the present invention will be described in detail with reference to experimental examples.

実験例1 前記方法で製造した再構成基底膜6ml上に、1枚あたり
6×106個の線維芽細胞を植え、5%CO2、95%大
気、37℃でゲルの収縮状態を観察した。ゲル収縮の度
合は、基底膜上で培養している細胞の活発さと関係して
いることが、知られている。結果は第3図に示し、図
中、横軸は移植後の日数、縦軸はゲルの直径(cm)を表
す。
Experimental Example 1 6 × 10 6 fibroblasts were planted per one sheet on 6 ml of the reconstituted basement membrane prepared by the above method, and the contracted state of the gel was observed at 37 ° C. in 5% CO 2 , 95% atmosphere. . It is known that the degree of gel contraction is related to the activity of cells cultured on the basement membrane. The results are shown in FIG. 3, in which the horizontal axis represents the number of days after transplantation and the vertical axis represents the gel diameter (cm).

実験例II 前記方法で製造した再構成基底膜上にて、モルモット皮
膚上皮細胞を培養したところ著しく増殖し、3週間経過
した時点で上皮細胞の均一な多層構造が形成されること
を光学及び電子顕微鏡で観察した。さらに上記の培養上
皮細胞をモルモット背部に移植したところ、正常な角質
の形成が観察され、さらに移植後4週間観察を続けたと
ころ移植片の拒絶反応はなく、また皮膚のひこう等のケ
ロイド上瘢痕の形成は認められなかった。
Experimental Example II When guinea pig skin epithelial cells were cultured on the reconstituted basement membrane produced by the above-mentioned method, they proliferated significantly, and a uniform multi-layer structure of epithelial cells was formed after 3 weeks. It was observed under a microscope. Furthermore, when the above cultured epithelial cells were transplanted to the back of the guinea pig, normal keratin formation was observed, and when the observation was continued for 4 weeks after transplantation, there was no rejection of the transplant, and on keloids such as the skin's plaque. No scar formation was observed.

以上から明らかな様に本発明は天然の基底膜と構造的に
極めて均等な人工基底膜とその製造方法を提示したもの
であり、上皮系細胞の培養において著効を有するものと
言い得る。
As is apparent from the above, the present invention provides an artificial basement membrane structurally extremely equivalent to a natural basement membrane and a method for producing the same, and it can be said that the present invention has a remarkable effect in culturing epithelial cells.

【図面の簡単な説明】[Brief description of drawings]

第1図及び第2図は本発明人工基底膜の製造方法を示し
た説明図である。 第3図は、実験例Iの結果を示す説明図である。
1 and 2 are explanatory views showing the method for producing an artificial basement membrane of the present invention. FIG. 3 is an explanatory diagram showing the results of Experimental Example I.

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】コラーゲンゲル中で培養した繊維芽細胞を
基板とし、その上にIV型コラーゲン、糖タンパク質、ム
コ多糖を含む構成成分を重層し、生理的条件下でゲル化
させることを特徴とする人工基底膜の製造方法。
1. A fibroblast cultured in a collagen gel is used as a substrate, and constituent components including type IV collagen, glycoprotein, and mucopolysaccharide are layered thereon, and gelled under physiological conditions. A method for producing an artificial basement membrane.
JP61004310A 1986-01-14 1986-01-14 Artificial basement membrane and method for producing the same Expired - Lifetime JPH0655218B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP61004310A JPH0655218B2 (en) 1986-01-14 1986-01-14 Artificial basement membrane and method for producing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61004310A JPH0655218B2 (en) 1986-01-14 1986-01-14 Artificial basement membrane and method for producing the same

Publications (2)

Publication Number Publication Date
JPS62270162A JPS62270162A (en) 1987-11-24
JPH0655218B2 true JPH0655218B2 (en) 1994-07-27

Family

ID=11580911

Family Applications (1)

Application Number Title Priority Date Filing Date
JP61004310A Expired - Lifetime JPH0655218B2 (en) 1986-01-14 1986-01-14 Artificial basement membrane and method for producing the same

Country Status (1)

Country Link
JP (1) JPH0655218B2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2667246A1 (en) * 1990-10-02 1992-04-03 Imedex BIOMATERIAL BASED ON COLLAGEN AND APPLICATIONS.
JP4074043B2 (en) * 2000-03-27 2008-04-09 株式会社資生堂 Skin basement membrane formation promoter, artificial skin formation promoter, and method for producing artificial skin

Also Published As

Publication number Publication date
JPS62270162A (en) 1987-11-24

Similar Documents

Publication Publication Date Title
US6043089A (en) Skin culture and process for preparing the same
DE69017820T2 (en) IMPLANTS FOR LARGE QUANTITIES OF CELLS ON POLYMERIC MATRICES.
US5716411A (en) Method of skin regeneration using a collagen-glycosaminoglycan matrix and cultured epithelial autograft
Eaglstein et al. Tissue engineering and the development of Apligraf®, a human skin equivalent
Horch et al. Tissue engineering of cultured skin substitutes
CA1340581C (en) Chimeric neomorphogenesis of organs by controlled cellular implantation using artificial matrices
DE69219613T2 (en) PREVASCULARIZED POLYMER IMPLANTS FOR ORGAN TRANSPLANTATION
Hafemann et al. Use of a collagen/elastin-membrane for the tissue engineering of dermis
Sheridan et al. Skin substitutes in burns
Hansbrough et al. Burn wound closure with cultured autologous keratinocytes and fibroblasts attached to a collagen-glycosaminoglycan substrate
Compton et al. Organized skin structure is regenerated in vivo from collagen-GAG matrices seeded with autologous keratinocytes
Jones et al. A guide to biological skin substitutes
US6733530B1 (en) Material and method for engraftment of a composite biocompatible skin graft on the neodermis of artificial skin
US5741685A (en) Parenchymal cells packaged in immunoprotective tissue for implantation
Orgill et al. Vascularized collagen-glycosaminoglycan matrix provides a dermal substrate and improves take of cultured epithelial autografts
Kuroyanagi et al. A cultured skin substitute composed of fibroblasts and keratinocytes with a collagen matrix: preliminary results of clinical trials
Han et al. Effect of poly (3‐hydroxybutyrate‐co‐3‐hydroxyvalerate) nanofiber matrices cocultured with hair follicular epithelial and dermal cells for biological wound dressing
Cairns et al. Skin replacements: the biotechnological quest for optimal wound closure
WO1980001350A1 (en) Skin-equivalent
Orgill et al. The use of collagen‐GAG membranes in reconstructive surgery
EP0091952A1 (en) Cell-seeding procedures involving fibrous lattices.
Butler et al. Simultaneous in vivo regeneration of neodermis, epidermis, and basement membrane
Kane et al. 7.10 Burn Dressings
DE10041468C1 (en) Skin matrix for covering and regeneration of injured skin areas and process for their production
Sheridan et al. Alternative wound coverings